Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1: A Potential Compound to Improve Spermatogenesis in Mouse Model of Diabetes Mellitus
Bella Amanda, Zakiyatul Faizah, Cennikon Pakpahan, M Aminudin Aziz, Berliana Hamidah, Faisal Yusuf Ashari, Delvac Oceandy, Jun Lu · 2024
Read Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1: A Potential Compound to Improve Spermatogenesis in Mouse Model of Diabetes Mellitus by Bella Amanda, Zakiyatul Faizah, Cennikon Pakpahan, M Aminudin Aziz, Berliana Hamidah, Faisal Yusuf Ashari, Delvac Oceandy, Jun Lu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11591716.txt.
Description
Bella Amanda and co-authors test a pathway blocking compound for rescuing sperm production in diabetic mice, in a 2024 study. Diabetes commonly disrupts sperm making and drives infertility, yet few treatments target cell growth in the testis. The compound blocks a brake in the Hippo pathway, which should free cells to divide and repair.
Diabetic mice on the compound grew a wider sperm making zone and swam better than untreated controls. Treated diabetic mice also trended toward better sperm counts and motion. Tube measures inside the testis were compared in fine detail. The authors frame the drug as a fertility lead worth human study.
Catalog record
| CREATOR | Bella Amanda, Zakiyatul Faizah, Cennikon Pakpahan, M Aminudin Aziz, Berliana Hamidah, Faisal Yusuf Ashari, Delvac Oceandy, Jun Lu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |